Skip to content

Effects of Non-invasive Direct Current Technique in Schizophrenia

Neurobiological and Genetic Correlates of the Effect of Transcranial Direct Current Stimulation on Auditroy Verbal Hallucinations in Schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006612
Enrollment
42
Registered
2016-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Schizophrenia

Interventions

Intervention1: Transcranial Direct Current Stimulation (tDCS): Transcranial direct current stimulation (tDCS) is a non-invasive neuromodulatory brain stimulation technique that delivers low intensity,
1) a fade-in phase, ramps up the current to the desired intensity (20 s), 2) the stimulation phase that continues at a target intensity (typically 2 mA, for 20 min), and 3) a fade-out phase where curr
20 s). 4) 2 sessions/day 3 hours apart for 5 continuous days Control Intervention1: Placebo arm of transcranial direct current stimulation (tDCS): For the sham tDCS condition, the actual stimulation o

Sponsors

National Institute of Mental Health and NeuroSciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosis of schizophrenia/schizophreniform disorder as per DSM-V criteria (Diagnostic and Statistical Manual for Mental Disorders, American Psychiatric Association, 2013); 2) Clinically Significant Auditory Verbal Hallucinations as defined by the Auditory Hallucination Rating Scale (Haddock et al 1999) items on frequency, duration and disruption each having a score >= 2; 3) Stable antipsychotic medication dose atleast for the past 4 weeks with no change in auditory hallucination severity; 4) Age: 18 â?? 45 years; 5) Both sexes; 6) Right Handedness and 7) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Features suggestive of psychiatric emergency (suicidal risk, aggression, excitement, catatonia, prolonged nutritional deprivation or any other status requiring intensive clinical care); 2) Any contraindication to tDCS procedure â?? (i) metal in the head, (ii) implanted brain medical devices, (iii) local lesion or injury in the scalp / head; 3) Any co-morbid psychiatric diagnosis; 4) Left Handedness.

Design outcomes

Primary

MeasureTime frame
1. Improvement in auditory verbal halluciantion 2. Changes in hemodynamic response, fronto-temporo-parietal network connectivity 3. Profile of auditory processing efficiency 4. Impact of neuroplasticity gene polymorphismTimepoint: Assessments will be done twice, before starting tDCS and after completion of tDCS 5 days course

Secondary

MeasureTime frame
CognitionTimepoint: Assessments will be done twice, before starting tDCS and after completion of tDCS 5 days course

Countries

India

Contacts

Public ContactDr Venkatasubramanian

National Institute of Mental Health and Neurosciences

venkat.nimhans@gmail.com08026995366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026